AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,000 | -69.2% | 135,721 | -10.7% | 0.00% | – |
| Q2 2022 | $26,000 | -70.5% | 151,990 | -19.2% | 0.00% | – |
| Q1 2022 | $88,000 | -42.9% | 188,190 | -30.5% | 0.00% | – |
| Q4 2021 | $154,000 | -75.8% | 270,933 | -29.3% | 0.00% | -100.0% |
| Q3 2021 | $636,000 | +8.7% | 383,137 | +9.4% | 0.00% | 0.0% |
| Q2 2021 | $585,000 | -21.9% | 350,202 | -21.0% | 0.00% | 0.0% |
| Q1 2021 | $749,000 | -22.8% | 443,291 | -27.3% | 0.00% | -50.0% |
| Q4 2020 | $970,000 | +58.8% | 609,885 | -4.5% | 0.00% | 0.0% |
| Q3 2020 | $611,000 | +85.7% | 638,787 | +23.7% | 0.00% | 0.0% |
| Q2 2020 | $329,000 | +94.7% | 516,500 | +27.1% | 0.00% | +100.0% |
| Q1 2020 | $169,000 | +2314.3% | 406,460 | +3389.2% | 0.00% | – |
| Q4 2019 | $7,000 | – | 11,649 | +3237.8% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 349 | -98.8% | 0.00% | – |
| Q2 2019 | $11,000 | -42.1% | 29,349 | -14.3% | 0.00% | – |
| Q1 2019 | $19,000 | -51.3% | 34,230 | -65.5% | 0.00% | – |
| Q4 2018 | $39,000 | -40.0% | 99,145 | -22.5% | 0.00% | -100.0% |
| Q3 2018 | $65,000 | -74.5% | 127,961 | +10.6% | 0.00% | -50.0% |
| Q2 2018 | $255,000 | +90.3% | 115,699 | +193.3% | 0.00% | +100.0% |
| Q1 2018 | $134,000 | -88.8% | 39,447 | -86.6% | 0.00% | -87.5% |
| Q4 2017 | $1,201,000 | +4041.4% | 295,057 | +511.3% | 0.01% | – |
| Q3 2017 | $29,000 | -6.5% | 48,268 | -18.4% | 0.00% | – |
| Q2 2017 | $31,000 | -60.3% | 59,184 | -39.6% | 0.00% | -100.0% |
| Q1 2017 | $78,000 | -51.2% | 97,991 | -45.0% | 0.00% | -50.0% |
| Q4 2016 | $160,000 | +79.8% | 178,085 | +47.3% | 0.00% | +100.0% |
| Q3 2016 | $89,000 | -49.7% | 120,867 | -11.7% | 0.00% | -50.0% |
| Q2 2016 | $177,000 | -8.3% | 136,927 | +59.3% | 0.00% | -33.3% |
| Q1 2016 | $193,000 | -42.4% | 85,959 | -10.2% | 0.00% | -25.0% |
| Q4 2015 | $335,000 | +13.9% | 95,756 | -6.0% | 0.00% | 0.0% |
| Q3 2015 | $294,000 | +180.0% | 101,896 | +131.1% | 0.00% | +300.0% |
| Q2 2015 | $105,000 | -88.1% | 44,091 | -62.3% | 0.00% | -92.9% |
| Q1 2015 | $882,000 | +44.6% | 117,083 | -34.1% | 0.01% | +55.6% |
| Q4 2014 | $610,000 | -25.5% | 177,734 | -23.4% | 0.01% | -30.8% |
| Q3 2014 | $819,000 | -34.2% | 232,081 | +55.7% | 0.01% | -31.6% |
| Q2 2014 | $1,245,000 | +11.5% | 149,097 | -15.2% | 0.02% | 0.0% |
| Q1 2014 | $1,117,000 | -15.1% | 175,865 | -4.6% | 0.02% | -5.0% |
| Q4 2013 | $1,315,000 | +23.0% | 184,383 | +29.4% | 0.02% | 0.0% |
| Q3 2013 | $1,069,000 | +82.7% | 142,490 | +40.5% | 0.02% | +42.9% |
| Q2 2013 | $585,000 | – | 101,397 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVA Family Office, LLC | 1,173,200 | $1,865,000 | 1.14% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $1,387,000 | 0.82% |
| Cypress Capital Management LLC (WY) | 214,575 | $341,000 | 0.30% |
| Western Wealth Management, LLC | 982,350 | $1,562,000 | 0.23% |
| SRS Capital Advisors, Inc. | 615,659 | $979,000 | 0.14% |
| Willis Investment Counsel | 1,213,053 | $1,929,000 | 0.13% |
| Harvest Investment Services, LLC | 124,423 | $197,000 | 0.10% |
| Transform Wealth, LLC | 205,481 | $327,000 | 0.07% |
| COURIER CAPITAL LLC | 379,973 | $604,000 | 0.07% |
| BRIGHTON JONES LLC | 398,912 | $634,000 | 0.04% |